MLH1 and neoplasm: A recent study firstly provided longitudinal evidence on molecular markers (including BRAF V600E, CIMP, and MLH1 methylation) of SPs, suggesting that epigenetic defect of MLH1 methylation was in relation to subsequent advanced neoplasms (26).